期刊文献+

肥胖儿童非酒精性脂肪性肝病血清瘦素水平分析

原文传递
导出
摘要 目的:检测肥胖儿童和正常对照儿童血清瘦素水平,探讨瘦素与非酒精性脂肪性肝病的相关性。方法:对100例肥胖儿童及100例正常对照儿童测量身高、体重,计算体重指数(BMI);检测空腹血糖(FPG)、胰岛素(FINS)、谷丙氨酸氨基转移酶(ALT)总胆固醇(Tc)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A(ApoA)、载脂蛋白B(ApoB);胰岛素抵抗采用稳态模式评估法的胰岛素抵抗指数(HOMA-IR)指标;血清瘦素采用酶联免疫吸附试验检测。对肥胖儿童进行肝脏B超检查,并对非酒精性脂肪性肝病病变程度分为轻、中、重度,分别积分1、2、3分。结果:肥胖组瘦素、BMI、ALT、TG、LDL-C、TC、APB、FINS、HOMA-IR较对照组高(P<0.05),而HDL-C较对照组低P<0.05。100例肥胖儿童组中根据B超发现非酒精脂肪性肝病(NAFLD)55例,与其余45例单纯肥胖儿童结果比较显示:NAFLD组瘦素、BMI、TG、ALT、FINS、HOMA-IR水平较高P<0.05,而HDL-C水平较低P<0.05;多元Logistic回归分析显示BMI、瘦素和TG水平是脂肪肝形成的主要危险因素;多元线性回归分析显示瘦素和BMI与NAFLD评分独立相关(P值<0.05)。结论:高瘦素水平是肥胖儿童非酒精性脂肪性肝病的危险因素之一,监测血清瘦素水平有助于判断非酒精性脂肪性肝病的病变程度。
出处 《中国农村卫生事业管理》 2013年第3期329-331,共3页 Chinese Rural Health Service Administration
基金 浙江省医药卫生科学研究基金(2008A161)
  • 相关文献

参考文献7

  • 1Bugianesi E, Marzocchi R, Villanova N, et, al. Non- alcohol- ic fatty liver disease/non - alcoholic steatohepatitis (NAFLD/NASH) : treatment[J]. Best pract Res Clin Gas- troenterol, 2004,18(6) : 1105-1116.
  • 2杨建锋,陈芝芸,项柏康,姚定国,严茂样,何蓓晖.非酒精性脂肪肝患者血清瘦素的变化[J].中华消化杂志,2004,24(12):752-753. 被引量:19
  • 3胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2008:336:1167.
  • 4Roberts EA. Steatohepatitis in children[J]. Best pract Res Clin Gastroente rol,2002,16(5) :749-765.
  • 5赵彩彦,李丽.瘦素与脂肪性肝病[J].中华肝脏病杂志,2004,12(8):510-512. 被引量:13
  • 6Leclercq IA, Farell GC, Schriemer R, et al. Leptin is essen- tial for the hepatic fibrogenic response to chronic liver injury [J]. J Hepatol,2002,37(2) :206-213.
  • 7Hookman P, Barkin JS. Current biochemical studies of non- alcoholic fatty liver disease and nonalcoholic s.teatohepatitis suggest a new therapeutic approach[J]. Am J Gastrenterol. 2003,98(9) : 2093-2097.

二级参考文献17

  • 1Diehl AM.Nonalcoholic Steatosis and Steatohepatitis V.Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines.Am J Physiol Gastrointest Liver Physiol,2002,282:G1-G5.
  • 2Saxena NK,Ikeda K,Rockey DC,et al.Leptin in hepatic fibrosis:evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice.Hepatology,2002,35:762-771.
  • 3Kielar D,Clark JS,Ciechanowicz A.Leptin receptor isoforms expressed in human adipose tissue.Metabolism,1998,47:844-847.
  • 4Szanto I,Kahn CR.Selective interaction between leptin and insulin signaling pathways in a hepatic cell line.Proc Natl Acad Sci USA,2000,97:2355-2360.
  • 5Tobe K,Ogura T,Tsukamoto C,et al.Relationship between serum leptin and fatty liver in Japanese male adolescent university students.J Gastroenterol,1999,94:3328-3335.
  • 6Chitturi S,Farrell G,Frost L,et al.Serum leptin in NASH correlates with hepatic steatosis but not fibrosis:a manifestation of lipotoxicity?Hepatology,2002,36:403-409.
  • 7Giannini E,Botta F,Cataldi A,et al.Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.Hepatogastroenterology,1999,46:2422-2425.
  • 8McCullough AJ,Falck Ytter Y.Body composition and hepatic steatosis as precursors for fibrotic liver disease.Hepatology,1999,29:1328-1330.
  • 9Leclercq IA,Farrell GC,Schriemer R,et al.Leptin is essential for the hepatic fibrogenic response to chronic liver injury.J Hepatol,2002,37:206-213.
  • 10Kazuyuki T,Ryo S,Masashi A ,et al.Increased expression of the sterol regulatory element-binding protein-I gene in insulin receptor substrate-2 (-/-) mouse liver.Biol Chem,2001,276:38337-38340.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部